Bactericidal Permeability Increasing Protein (BPI)-ANCA-A Marker of Chronic Inflammatory Bowel Diseases and Inflammatory Hepatobiliary Diseases;Bactericidal permeability increasing protein (BPI)-ANCA markiert chronische entzundliche darmerkrankungen und entzundliche hepatobiliare erkrankungen

Medizinische Klinik

Volumn 92, Issue 7, 1997, Pages 389-393

  Schnabel, Armin ^a,b   Csernok, Elena ^a   Schultz, Hendrik ^a   Stoffel, Markus ^a   Herzberg, Christian ^a   Carroll, Stephan F ^a   Gross, Wolfgang L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Rheumaklinik Bad Bramstedt   (Germany)

Author keywords

Antineutrophil cytoplasmic antibodies; Autoimmunity; Chronic; Inflmmatory Bowel Diseases; Vasculitides

Indexed keywords

AUTOANTIBODY; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; COLLAGEN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY TRACT INFLAMMATION; COLLAGEN DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATOBILIARY DISEASE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RHEUMATIC DISEASE; SYSTEMIC VASCULITIS; ULCERATIVE COLITIS;

EID: 0030744388     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03042568     Document Type: Article

References (31)

1. American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthr. and Rheum. 33 (1990), 1074-1137.
2. Arditi, M., J. Zhou, S. H. Huang, P. M. Luckett, M. N. Marra, K. S. Kim: Bactericidal/permeability increasing protein protects vascular endothelium from lipopolysaccharide-induced activation and injury. Infect. and Immun. 62 (1994), 3930-3936.
3. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, F. J. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, T. A. Medsger, D. M. Mitchell, D. H. Neustadt, R. Pinals, J. G. Schaller, J. T. Sharp, R. L. Wilder, G. G. Hunder: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr. and Rheum. 31 (1988), 315-324.
4. Braun, M. G., E. Csernok, W. H. Schmitt, W. L. Gross: Incidence, target antigens and clinical implications of anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis. J. Rheum. 23 (1996), 826-830.
5. Cambridge, G., D. S. Rampton, T. R. J. Stevens, D. A. McCarthy, K. M. Kamm, B Leaker: Anti-neutrophil antibodies in inflammatory bowel diseases: Prevalence and diagnostic role. Gut 33 (1992), 668-674.
6. Dougados, M., S. van der Linden, R. Juhlin, B. Huitfeldt, B. Amor, A. Calin, A. Cats, B. Dijkinan, I. Olivieri, G. Pasero, E. Veys, H. Zeidler: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthr. and Rheum. 34 (1991), 1218-1227.
7. Duerr, R. H., S. R. Targan, C. J. Landers, L. R. Sutherland, F. Shanahan: Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 100 (1990), 1590-1596.
8. Duerr, R. H., S. R. Targan, C. J. Landers, N. F. LaRusso, K. L. Lindsay, R. H. Wiesner, F. Shanahan: Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerarive colitis. Gastroenterology 100 (1991), 1385-1391.
9. Falk, R. J., M. Becker, R. Terrell, J. C. Jennette: Antigen specificity of pANCA and of cANCA. Amer. J. Kidney Dis. 19 (1991), 197
10. Gross, W. L , W. H. Schmitt, E. Csernok: ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin. exp. Immunol. 91 (1993), 1-12.
11. Gross, W. L., E. Csernok: Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr. Opin. Rheum. 7 (1995), 11-19.
12. Hagen, E. C., K. Andrassy, E. Csernok, M. R. Daha, G. Gaskin, W. L. Gross, P. Lesavre, J. Lüdemann, C. D. Pusey, N. Rasmussen, C. O. S. Savage, A. Sinico, A. Wiik, F. van der Woude: The value of indirect immunofluorescence and solid phase techniques for ANCA detection. J. Immunol. Meth. 159 (1993), 1-16.
13. Halbwachs-Mecarelli, L , P. Nusbaum, L. H. Noel, D. Reumaux, S. Erlinger, J. P. Grünfeld, P. Lesavre: Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. exp. Immunol. 90 (1992), 79-84.
14. Hauschild, S., K. Schwarting, E. Csernok, G. Jantschek, D. Ludwig, E. F. Stange, W L. Gross: ANCA-finespecificities and disease activity in inflammatory bowel diseases. Clin. exp. Immunol 93, Suppl. 1 (1993), 46.
15. Jennette, J. C , R. J. Falk, K. Andrassy, P. A. Bacon, J. Churg, W. L. Gross, E. C. Hagen, G. S. Hoffman, G. G. Hunder, C. G M. Kallenberg, R. T. McCluskey, R. A. Sinico, A. J. Rees, A. Leendert van ES, R. Waldherr, A. Wiik: Nomenclature of systemic vasculitides. Arthr. and Rheum. 37 (1994), 187-192.
16. Khan, M. A.: An overview of clinical spectrum and heterogeneity of spondylarthropathies. Rheum. Dis. Clin, N. Amer. 18 (1992), 1-10.
17. Mulder, A. H. L., G, Horst, E. B. Haagsma, P. C. Limburg, J. H. Kleibeuker, C. G. M. Kallenberg: Prevalence and characterization of anti-neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 17 (1993), 411-417.
18. Mulder, A. H. L., J. Broekroelofs, G. Horst, P. C. Limburg, G. F. Nelis: Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin. exp. Immunol. 95 (1994), 490-497.
19. Nölle, B., U. Specks, J. Lüdemann, M. S. Rohrbach, R. A. DeRemee, W. L. Gross. Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener's granulomatosis. Ann. intern. Med. 111 (1989), 28-40.
20. Rump, J. A., J. Schölmerich, V. Gross, M. Roth, R. Helfesrieder, A. Rautmann, J. Lüdemann, W. L. Gross, H. H. Peter A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative Colitis but not in Crohn's disease. Immunbiology 181 (1991), 406-413.
21. Schellong, S. M., M. Haubitz, M. Manns, K. Alexander: Prospective study of pANCA in inflammatory bowel disease. Clin. exp. Immunol. 101, Suppl. 1 (1995), 45.
22. Schnabel, A., E. Csemok, D. A Isenberg, C. Mrowka, W. L. Gross. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus-prevalence, specificities, and clinical significance. Arthr. and Rheum. 38 (1994), 633-637.
23. Schnabel, A., W. L. Gross: Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int. Arch. Allergy 109 (1996), 201-206.
24. Snook, J. A., R. W. Chapman, K. Fleming, D. P. Jewell: Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. exp. Immunol. 76 (1989), 30-33.
25. Stoffel, M., E. Csernok, C. Herzberg, T. Johnston, S. F. Carroll, W. L. Gross: Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin. exp. Immunol. 104 (1996), 54-59.
26. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, R. J. Winchester: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr. and Rheum. 25 (1982), 1271-1277.
27. Tedesco, F. H.: Differential diagnosis of ulcerative colitis and Crohn's ileocolitis and other inflammatory disease of the bowel. Med. Clin. N. Amer. 64 (1980), 1173-1183.
28. Weiss, J., P. Elsbach, I. Olsson, H. Odeberg: Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. biol. Chem. 253 (1978), 2664-2672
29. Yang, J. J., M. Backer, R. Tuttle, A. Pereira, J. C. Jennette, R J. Falk: Specificity of cytoplasmic-pattern anti-neutrophil cytoplasmic autoantibodies (cANCA) for bactericidal permeability-increasing protein (BPI). Clin. exp. Immunol. 101, Suppl. 1 (1995), 50.
30. Zhao, M. H., S. J. Jones, C. M. Lockwood: Bactericidal/permeability increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin. exp. Immunol. 99 (1995), 49-56.
31. Zhao, M. H., D. R. W. Jayne, L. G. Ardiles, F. Culley, M. E. Hodson, C. M. Lockwood: Antibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. Quart. J. Med. 89 (1996), 259-265.